Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Evolution of clinical trials in multiple sclerosis.

Zhang Y, Salter A, Wallström E, Cutter G, Stüve O.

Ther Adv Neurol Disord. 2019 Feb 21;12:1756286419826547. doi: 10.1177/1756286419826547. eCollection 2019. Review.

2.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators.

Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23. Erratum in: Lancet. 2018 Nov 17;392(10160):2170.

PMID:
29576505
3.

A COMPARATIVE STUDY OF ORGAN DOSES ASSESSMENT FOR PATIENTS UNDERGOING CONVENTIONAL X-RAY EXAMINATIONS: PHANTOM EXPERIMENTS VS. CALCULATIONS.

Golikov V, Barkovsky A, Wallstrom E, Cederblad Å.

Radiat Prot Dosimetry. 2018 Jan 1;178(2):223-234. doi: 10.1093/rpd/ncx102.

PMID:
28981902
4.

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.

Kappos L, Li DK, Stüve O, Hartung HP, Freedman MS, Hemmer B, Rieckmann P, Montalban X, Ziemssen T, Hunter B, Arnould S, Wallström E, Selmaj K.

JAMA Neurol. 2016 Sep 1;73(9):1089-98. doi: 10.1001/jamaneurol.2016.1451.

PMID:
27380540
5.

Diagnosis of asthma in primary health care: a pilot study.

Ringsberg KC, Bjärneman P, Larsson R, Wallström E, Löwhagen O.

J Allergy (Cairo). 2014;2014:898965. doi: 10.1155/2014/898965. Epub 2014 Apr 10.

6.

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.

Selmaj K, Li DK, Hartung HP, Hemmer B, Kappos L, Freedman MS, Stüve O, Rieckmann P, Montalban X, Ziemssen T, Auberson LZ, Pohlmann H, Mercier F, Dahlke F, Wallström E.

Lancet Neurol. 2013 Aug;12(8):756-67. doi: 10.1016/S1474-4422(13)70102-9. Epub 2013 Jun 11. Erratum in: Lancet Neurol. 2013 Sep;12(9):846.

PMID:
23764350
7.

The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.

Gergely P, Nuesslein-Hildesheim B, Guerini D, Brinkmann V, Traebert M, Bruns C, Pan S, Gray NS, Hinterding K, Cooke NG, Groenewegen A, Vitaliti A, Sing T, Luttringer O, Yang J, Gardin A, Wang N, Crumb WJ Jr, Saltzman M, Rosenberg M, Wallström E.

Br J Pharmacol. 2012 Nov;167(5):1035-47. doi: 10.1111/j.1476-5381.2012.02061.x.

8.

Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.

Hopia L, Thangarajh M, Khademi M, Laveskog A, Wallström E, Svenungsson E, Andersson M.

Scand J Rheumatol. 2011;40(5):363-72. doi: 10.3109/03009742.2010.550900. Epub 2011 May 18.

PMID:
21585290
9.

RGMA and IL21R show association with experimental inflammation and multiple sclerosis.

Nohra R, Beyeen AD, Guo JP, Khademi M, Sundqvist E, Hedreul MT, Sellebjerg F, Smestad C, Oturai AB, Harbo HF, Wallström E, Hillert J, Alfredsson L, Kockum I, Jagodic M, Lorentzen J, Olsson T.

Genes Immun. 2010 Jun;11(4):279-93. doi: 10.1038/gene.2009.111. Epub 2010 Jan 14.

PMID:
20072140
10.

Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?

Brynedal B, Khademi M, Wallström E, Hillert J, Olsson T, Duvefelt K.

Neurobiol Dis. 2010 Mar;37(3):613-21. doi: 10.1016/j.nbd.2009.11.014. Epub 2009 Nov 26.

PMID:
19944761
11.

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Iacobaeus E, Ryschkewitsch C, Gravell M, Khademi M, Wallstrom E, Olsson T, Brundin L, Major E.

Mult Scler. 2009 Jan;15(1):28-35. doi: 10.1177/1352458508096870. Epub 2008 Sep 19.

12.

Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallström E, Lobell A, Brundin L, Lassmann H, Harris RA.

J Leukoc Biol. 2008 Nov;84(5):1248-55. doi: 10.1189/jlb.1207844. Epub 2008 Jul 21.

PMID:
18644848
13.

Vra4 congenic rats with allelic differences in the class II transactivator gene display altered susceptibility to experimental autoimmune encephalomyelitis.

Harnesk K, Swanberg M, Ockinger J, Diez M, Lidman O, Wallström E, Lobell A, Olsson T, Piehl F.

J Immunol. 2008 Mar 1;180(5):3289-96.

14.

Induction of systemic TNFalpha in natalizumab-treated multiple sclerosis.

Khademi M, Stol D, Olsson T, Wallström E.

Eur J Neurol. 2008 Mar;15(3):309-12. doi: 10.1111/j.1468-1331.2007.02037.x. Epub 2008 Jan 9.

PMID:
18190511
15.

Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.

Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J.

Nat Genet. 2007 Sep;39(9):1108-13. Epub 2007 Jul 29.

PMID:
17660816
16.

Evaluation of conversion coefficients from measurable to risk quantities for external exposure over contaminated soil by use of physical human phantoms.

Golikov V, Wallström E, Wöhni T, Tanaka K, Endo S, Hoshi M.

Radiat Environ Biophys. 2007 Nov;46(4):375-82. Epub 2007 Jul 21.

PMID:
17643259
17.

Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.

Eltayeb S, Berg AL, Lassmann H, Wallström E, Nilsson M, Olsson T, Ericsson-Dahlstrand A, Sunnemark D.

J Neuroinflammation. 2007 May 7;4:14.

18.

Genetics of autoimmune neuroinflammation.

Olsson T, Jagodic M, Piehl F, Wallström E.

Curr Opin Immunol. 2006 Dec;18(6):643-9. Epub 2006 Sep 14. Review.

PMID:
16973343
19.

Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis.

Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T.

J Immunol. 2006 May 15;176(10):6055-64.

20.

No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab.

Andersson M, Svenungsson E, Khademi M, Lampa J, Brundin L, Wallström E.

Ann Rheum Dis. 2006 Sep;65(9):1237-40. Epub 2006 Apr 10.

21.

External and internal irradiation of a rural Bryansk (Russia) population from 1990 to 2000, following high deposition of radioactive caesium from the Chernobyl accident.

Thornberg C, Vesanen R, Wallström E, Zvonova I, Jesko T, Balonov M, Mattsson S.

Radiat Environ Biophys. 2005 Oct;44(2):97-106. Epub 2005 Nov 2.

PMID:
16175396
22.

CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.

Sunnemark D, Eltayeb S, Nilsson M, Wallström E, Lassmann H, Olsson T, Berg AL, Ericsson-Dahlstrand A.

J Neuroinflammation. 2005 Jul 29;2:17.

23.
24.

Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis.

Sheng JR, Jagodic M, Dahlman I, Becanovic K, Nohra R, Marta M, Iacobaeus E, Olsson T, Wallström E.

Genetics. 2005 May;170(1):283-9. Epub 2005 Feb 16.

25.

MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.

de Graaf KL, Wallström E, Muhallab S, Wiesmüller KH, Olsson T, Weissert R.

J Neuroimmunol. 2004 Oct;155(1-2):73-84.

PMID:
15342198
26.

An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci.

Jagodic M, Becanovic K, Sheng JR, Wu X, Bäckdahl L, Lorentzen JC, Wallström E, Olsson T.

J Immunol. 2004 Jul 15;173(2):1366-73.

27.

Current gene-mapping strategies in experimental models of multiple sclerosis.

Becanovic K, Jagodic M, Wallström E, Olsson T.

Scand J Immunol. 2004 Jul-Aug;60(1-2):39-51. Review.

28.

T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis.

Khademi M, Illés Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, Brundin L, Hannerz J, Martin C, Harris RA, Hafler DA, Kuchroo VK, Olsson T, Piehl F, Wallström E.

J Immunol. 2004 Jun 1;172(11):7169-76.

29.

Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.

Gonzalez H, Khademi M, Andersson M, Piehl F, Wallström E, Borg K, Olsson T.

J Neuroimmunol. 2004 May;150(1-2):139-44.

PMID:
15081258
30.

Differential expression of the chemokine receptors CX3CR1 and CCR1 by microglia and macrophages in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis.

Sunnemark D, Eltayeb S, Wallström E, Appelsved L, Malmberg A, Lassmann H, Ericsson-Dahlstrand A, Piehl F, Olsson T.

Brain Pathol. 2003 Oct;13(4):617-29.

PMID:
14655765
31.

Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease.

Eltayeb S, Sunnemark D, Berg AL, Nordvall G, Malmberg A, Lassmann H, Wallström E, Olsson T, Ericsson-Dahlstrand A.

J Neuroimmunol. 2003 Sep;142(1-2):75-85.

PMID:
14512166
32.

Paradoxical effects of arthritis-regulating chromosome 4 regions on myelin oligodendrocyte glycoprotein-induced encephalomyelitis in congenic rats.

Becanovic K, Bäckdahl L, Wallström E, Aboul-Enein F, Lassmann H, Olsson T, Lorentzen JC.

Eur J Immunol. 2003 Jul;33(7):1907-16.

33.

New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.

Becanovic K, Wallstrom E, Kornek B, Glaser A, Broman KW, Dahlman I, Olofsson P, Holmdahl R, Luthman H, Lassmann H, Olsson T.

J Immunol. 2003 Jan 15;170(2):1062-9.

34.

Prior poliomyelitis-evidence of cytokine production in the central nervous system.

Gonzalez H, Khademi M, Andersson M, Wallström E, Borg K, Olsson T.

J Neurol Sci. 2002 Dec 15;205(1):9-13.

PMID:
12409177
35.

Identification of rat quantitative trait loci that regulate LPS-induced pro-inflammatory cytokine responses.

Xu H, Wallstrom E, Becanovic K, Dahlman I, Lorentzen JC.

Scand J Immunol. 2002 Sep;56(3):248-53.

36.

MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury.

Storch MK, Weissert R, Steffer A, Birnbacher R, Wallström E, Dahlman I, Ostensson CG, Linington C, Olsson T, Lassmann H.

Brain Pathol. 2002 Jul;12(3):287-99.

PMID:
12146797
37.

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.

Killestein J, Olsson T, Wallström E, Svenningsson A, Khademi M, Blumhardt LD, Fagius J, Hillert J, Landtblom AM, Edenius C, Arfors L, Barkhof F, Polman CH.

Ann Neurol. 2002 Apr;51(4):467-74.

PMID:
11921052
38.

Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis.

Olsson T, Edenius C, Ferm M, Samuelson P, Torrång A, Wallström E, Khademi M, Andersson M, Arfors L.

Eur J Neurol. 2002 Mar;9(2):153-64.

PMID:
11882056
39.

Long-term external radiation exposure of inhabitants in the western Bryansk region of Russia as a consequence of the Chernobyl accident.

Thornberg C, Vesanen R, Wallström E, Zvonova I, Jesko T, Albinsson J, Börjesson J, Mattsson S.

Radiat Environ Biophys. 2001 Dec;40(4):287-94.

PMID:
11820737
40.

Polygenic control of autoimmune peripheral nerve inflammation in rat.

Dahlman I, Wallström E, Jiao H, Luthman H, Olsson T, Weissert R.

J Neuroimmunol. 2001 Oct 1;119(2):166-74.

PMID:
11585618
41.

Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis.

Di Marco R, Khademi M, Wallstrom E, Iacobaeus E, Salvaggio A, Caracappa S, Papoian R, Nicoletti F, Olsson T.

J Neuroimmunol. 2001 Jun 1;116(2):168-77.

PMID:
11438171
42.

Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement.

Abdul-Majid KB, Jirholt J, Stadelmann C, Stefferl A, Kjellén P, Wallström E, Holmdahl R, Lassmann H, Olsson T, Harris RA.

J Neuroimmunol. 2000 Nov 1;111(1-2):23-33.

PMID:
11063818
43.

Genetics of rat neuroinflammation.

Olsson T, Dahlman I, Wallström E, Weissert R, Piehl F.

J Neuroimmunol. 2000 Jul 24;107(2):191-200. Review.

PMID:
10854656
44.
45.

Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis.

Khademi M, Wallström E, Andersson M, Piehl F, Di Marco R, Olsson T.

J Neuroimmunol. 2000 Mar 1;103(2):202-10.

PMID:
10696916
46.

Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18.

Dahlman I, Wallström E, Weissert R, Storch M, Kornek B, Jacobsson L, Linington C, Luthman H, Lassmann H, Olsson T.

Hum Mol Genet. 1999 Nov;8(12):2183-90.

PMID:
10545597
47.
48.

Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10.

Di Marco R, Khademi M, Wallstrom E, Muhallab S, Nicoletti F, Olsson T.

J Autoimmun. 1999 Sep;13(2):187-95.

PMID:
10479387
49.

A gamma camera for measurements of internal contamination after a radiological accident.

Wallström E, Alpsten M, Mattsson S.

J Radiol Prot. 1999 Jun;19(2):143-54.

PMID:
10400152
50.

Feedback regulation of ornithine decarboxylase.

Wallström EL, Wendt A, Holmgren J, Persson L.

Biochem Soc Trans. 1998 Nov;26(4):S373. No abstract available.

PMID:
10047887

Supplemental Content

Loading ...
Support Center